Found: 12
Select item for more details and to access through your institution.
Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0110-0
- By:
- Publication type:
- Article
Exercise in newly diagnosed patients with multiple myeloma: A randomized controlled trial of effects on physical function, physical activity, lean body mass, bone mineral density, pain, and quality of life.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 298, doi. 10.1111/ejh.14215
- By:
- Publication type:
- Article
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 1, p. 34, doi. 10.1111/ejh.13709
- By:
- Publication type:
- Article
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 7, p. 1807, doi. 10.1002/cam4.1128
- By:
- Publication type:
- Article
Clarithromycin added to bortezomib‐cyclophosphamide‐dexamethasone impairs health‐related quality of life in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 1, p. 70, doi. 10.1111/ejh.13175
- By:
- Publication type:
- Article
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 3, p. 303, doi. 10.1111/ejh.12728
- By:
- Publication type:
- Article
Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E611, doi. 10.1002/ajh.24857
- By:
- Publication type:
- Article
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real‐world study.
- Published in:
- EJHaem, 2024, v. 5, n. 2, p. 316, doi. 10.1002/jha2.881
- By:
- Publication type:
- Article
Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma—a randomized controlled feasibility study.
- Published in:
- Pilot & Feasibility Studies, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40814-019-0518-2
- By:
- Publication type:
- Article
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188988
- By:
- Publication type:
- Article